APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Semi-synthetic β-lactam Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Semi-synthetic β-lactam Antibiotics Market Outlook and Growth Opportunities 2026

Report ID 174034660429 December 2025203 pages

Choose your research edition.

Industry ResearchSemi-synthetic β-lactam Antibiotics Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Semi-synthetic β-lactam Antibiotics Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Semi-synthetic β-lactam Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Semi-synthetic β-lactam Antibiotics Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Semi-synthetic β-lactam Antibiotics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Semi-synthetic β-lactam Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Semi-synthetic β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Semi-synthetic β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Semi-synthetic β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Semi-synthetic β-lactam Antibiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Semi-synthetic β-lactam Antibiotics market include GSK, Weiqida, Lukang Pharmaceuticals, United Pharmaceuticals, Huayao International, North China Pharmaceuticals, Harbin Pharmaceuticals, Chuanning Biopharmaceuticals and Changsheng Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Semi-synthetic β-lactam Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Semi-synthetic β-lactam Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Semi-synthetic β-lactam Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Semi-synthetic β-lactam Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Semi-synthetic β-lactam Antibiotics Segment by Company

GSK

Weiqida

Lukang Pharmaceuticals

United Pharmaceuticals

Huayao International

North China Pharmaceuticals

Harbin Pharmaceuticals

Chuanning Biopharmaceuticals

Changsheng Pharmaceuticals

Teva

Sun Pharma

Novartis

Mylan

Meiji Holdings

Hikma

DSM

Dr. Reddy

Cipla

Centrient Pharma

Aurubindo

Semi-synthetic β-lactam Antibiotics Segment by Type

Penicillin and Its Derivatives

Cephalosporins

Other

Semi-synthetic β-lactam Antibiotics Segment by Application

Hospital

Clinic

Other

Semi-synthetic β-lactam Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Semi-synthetic β-lactam Antibiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Semi-synthetic β-lactam Antibiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Semi-synthetic β-lactam Antibiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Semi-synthetic β-lactam Antibiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Semi-synthetic β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Semi-synthetic β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Semi-synthetic β-lactam Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Semi-synthetic β-lactam Antibiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Semi-synthetic β-lactam Antibiotics industry.

Chapter 3: Detailed analysis of Semi-synthetic β-lactam Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Semi-synthetic β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Semi-synthetic β-lactam Antibiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Semi-synthetic β-lactam Antibiotics Industry Trends Table 2. Semi-synthetic β-lactam Antibiotics Industry Drivers Table 3. Semi-synthetic β-lactam Antibiotics Industry Opportunities and Challenges Table 4. Semi-synthetic β-lactam Antibiotics Industry Restraints Table 5. Global Semi-synthetic β-lactam Antibiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Semi-synthetic β-lactam Antibiotics Revenue Share by Company (2021-2026) Table 7. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Company (2021-2026) Table 9. Global Semi-synthetic β-lactam Antibiotics Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Semi-synthetic β-lactam Antibiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Semi-synthetic β-lactam Antibiotics Key Company Manufacturing Base & Headquarters Table 12. Global Semi-synthetic β-lactam Antibiotics Company, Product Type & Application Table 13. Global Semi-synthetic β-lactam Antibiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Semi-synthetic β-lactam Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Penicillin and Its Derivatives Table 18. Significant Companies of Cephalosporins Table 19. Significant Companies of Other Table 20. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Type (2021-2026) Table 24. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Type (2027-2032) Table 25. Global Semi-synthetic β-lactam Antibiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Semi-synthetic β-lactam Antibiotics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Semi-synthetic β-lactam Antibiotics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Type (2021-2026) Table 29. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Application (2021-2026) Table 37. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Application (2027-2032) Table 38. Global Semi-synthetic β-lactam Antibiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Semi-synthetic β-lactam Antibiotics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Semi-synthetic β-lactam Antibiotics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Application (2021-2026) Table 42. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Application (2027-2032) Table 43. Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Semi-synthetic β-lactam Antibiotics Sales by Region (2021-2026) & (Tons) Table 45. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Region (2021-2026) Table 46. Global Semi-synthetic β-lactam Antibiotics Sales by Region (2027-2032) & (Tons) Table 47. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Region (2027-2032) Table 48. Global Semi-synthetic β-lactam Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Semi-synthetic β-lactam Antibiotics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Region (2021-2026) Table 51. Global Semi-synthetic β-lactam Antibiotics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Region (2027-2032) Table 53. Global Semi-synthetic β-lactam Antibiotics Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Semi-synthetic β-lactam Antibiotics Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Semi-synthetic β-lactam Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Semi-synthetic β-lactam Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Semi-synthetic β-lactam Antibiotics Sales by Country (2021-2026) & (Tons) Table 58. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2021-2026) Table 59. Global Semi-synthetic β-lactam Antibiotics Sales by Country (2027-2032) & (Tons) Table 60. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2027-2032) Table 61. Global Semi-synthetic β-lactam Antibiotics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Semi-synthetic β-lactam Antibiotics Sales Value Market Share by Country (2021-2026) Table 63. Global Semi-synthetic β-lactam Antibiotics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Semi-synthetic β-lactam Antibiotics Sales Value Market Share by Country (2027-2032) Table 65. GSK Company Information Table 66. GSK Business Overview Table 67. GSK Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. GSK Semi-synthetic β-lactam Antibiotics Product Portfolio Table 69. GSK Recent Development Table 70. Weiqida Company Information Table 71. Weiqida Business Overview Table 72. Weiqida Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Weiqida Semi-synthetic β-lactam Antibiotics Product Portfolio Table 74. Weiqida Recent Development Table 75. Lukang Pharmaceuticals Company Information Table 76. Lukang Pharmaceuticals Business Overview Table 77. Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 79. Lukang Pharmaceuticals Recent Development Table 80. United Pharmaceuticals Company Information Table 81. United Pharmaceuticals Business Overview Table 82. United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 84. United Pharmaceuticals Recent Development Table 85. Huayao International Company Information Table 86. Huayao International Business Overview Table 87. Huayao International Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Huayao International Semi-synthetic β-lactam Antibiotics Product Portfolio Table 89. Huayao International Recent Development Table 90. North China Pharmaceuticals Company Information Table 91. North China Pharmaceuticals Business Overview Table 92. North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 94. North China Pharmaceuticals Recent Development Table 95. Harbin Pharmaceuticals Company Information Table 96. Harbin Pharmaceuticals Business Overview Table 97. Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 99. Harbin Pharmaceuticals Recent Development Table 100. Chuanning Biopharmaceuticals Company Information Table 101. Chuanning Biopharmaceuticals Business Overview Table 102. Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 104. Chuanning Biopharmaceuticals Recent Development Table 105. Changsheng Pharmaceuticals Company Information Table 106. Changsheng Pharmaceuticals Business Overview Table 107. Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio Table 109. Changsheng Pharmaceuticals Recent Development Table 110. Teva Company Information Table 111. Teva Business Overview Table 112. Teva Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Teva Semi-synthetic β-lactam Antibiotics Product Portfolio Table 114. Teva Recent Development Table 115. Sun Pharma Company Information Table 116. Sun Pharma Business Overview Table 117. Sun Pharma Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Sun Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio Table 119. Sun Pharma Recent Development Table 120. Novartis Company Information Table 121. Novartis Business Overview Table 122. Novartis Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Novartis Semi-synthetic β-lactam Antibiotics Product Portfolio Table 124. Novartis Recent Development Table 125. Mylan Company Information Table 126. Mylan Business Overview Table 127. Mylan Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Mylan Semi-synthetic β-lactam Antibiotics Product Portfolio Table 129. Mylan Recent Development Table 130. Meiji Holdings Company Information Table 131. Meiji Holdings Business Overview Table 132. Meiji Holdings Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Meiji Holdings Semi-synthetic β-lactam Antibiotics Product Portfolio Table 134. Meiji Holdings Recent Development Table 135. Hikma Company Information Table 136. Hikma Business Overview Table 137. Hikma Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Hikma Semi-synthetic β-lactam Antibiotics Product Portfolio Table 139. Hikma Recent Development Table 140. DSM Company Information Table 141. DSM Business Overview Table 142. DSM Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. DSM Semi-synthetic β-lactam Antibiotics Product Portfolio Table 144. DSM Recent Development Table 145. Dr. Reddy Company Information Table 146. Dr. Reddy Business Overview Table 147. Dr. Reddy Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. Dr. Reddy Semi-synthetic β-lactam Antibiotics Product Portfolio Table 149. Dr. Reddy Recent Development Table 150. Cipla Company Information Table 151. Cipla Business Overview Table 152. Cipla Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 153. Cipla Semi-synthetic β-lactam Antibiotics Product Portfolio Table 154. Cipla Recent Development Table 155. Centrient Pharma Company Information Table 156. Centrient Pharma Business Overview Table 157. Centrient Pharma Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 158. Centrient Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio Table 159. Centrient Pharma Recent Development Table 160. Aurubindo Company Information Table 161. Aurubindo Business Overview Table 162. Aurubindo Semi-synthetic β-lactam Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 163. Aurubindo Semi-synthetic β-lactam Antibiotics Product Portfolio Table 164. Aurubindo Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Semi-synthetic β-lactam Antibiotics Distributors List Table 168. Semi-synthetic β-lactam Antibiotics Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Semi-synthetic β-lactam Antibiotics Product Image Figure 2. Global Semi-synthetic β-lactam Antibiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Semi-synthetic β-lactam Antibiotics Sales (2021-2032) & (Tons) Figure 5. Global Semi-synthetic β-lactam Antibiotics Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Semi-synthetic β-lactam Antibiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Penicillin and Its Derivatives Image Figure 10. Cephalosporins Image Figure 11. Other Image Figure 12. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Type (2021-2032) Figure 15. Global Semi-synthetic β-lactam Antibiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Semi-synthetic β-lactam Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Application (2021-2032) Figure 24. Global Semi-synthetic β-lactam Antibiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Semi-synthetic β-lactam Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Application (2021-2032) Figure 27. Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Semi-synthetic β-lactam Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Semi-synthetic β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Semi-synthetic β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Semi-synthetic β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Semi-synthetic β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Semi-synthetic β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Semi-synthetic β-lactam Antibiotics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Semi-synthetic β-lactam Antibiotics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin and Its Derivatives
  • Cephalosporins
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • GSK
  • Weiqida
  • Lukang Pharmaceuticals
  • United Pharmaceuticals
  • Huayao International
  • North China Pharmaceuticals
  • Harbin Pharmaceuticals
  • Chuanning Biopharmaceuticals
  • Changsheng Pharmaceuticals
  • Teva
  • Sun Pharma
  • Novartis
  • Mylan
  • Meiji Holdings
  • Hikma
  • DSM
  • Dr. Reddy
  • Cipla
  • Centrient Pharma
  • Aurubindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  4. 1.2.2 Global Semi-synthetic β-lactam Antibiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Semi-synthetic β-lactam Antibiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Semi-synthetic β-lactam Antibiotics Market Dynamics
  1. 2.1 Semi-synthetic β-lactam Antibiotics Industry Trends
  2. 2.2 Semi-synthetic β-lactam Antibiotics Industry Drivers
  3. 2.3 Semi-synthetic β-lactam Antibiotics Industry Opportunities and Challenges
  4. 2.4 Semi-synthetic β-lactam Antibiotics Industry Restraints
3 Semi-synthetic β-lactam Antibiotics Market by Company
  1. 3.1 Global Semi-synthetic β-lactam Antibiotics Company Revenue Ranking in 2025
  2. 3.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Company (2021-2026)
  3. 3.3 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Semi-synthetic β-lactam Antibiotics Average Price by Company (2021-2026)
  5. 3.5 Global Semi-synthetic β-lactam Antibiotics Company Ranking (2024-2026)
  6. 3.6 Global Semi-synthetic β-lactam Antibiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Semi-synthetic β-lactam Antibiotics Company Product Type and Application
  8. 3.8 Global Semi-synthetic β-lactam Antibiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Semi-synthetic β-lactam Antibiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Semi-synthetic β-lactam Antibiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Semi-synthetic β-lactam Antibiotics Market by Type
  1. 4.1 Semi-synthetic β-lactam Antibiotics Type Introduction
  2. 4.1.1 Penicillin and Its Derivatives
  3. 4.1.2 Cephalosporins
  4. 4.1.3 Other
  5. 4.2 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type
  6. 4.2.1 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Semi-synthetic β-lactam Antibiotics Sales Value by Type
  10. 4.3.1 Global Semi-synthetic β-lactam Antibiotics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Semi-synthetic β-lactam Antibiotics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Type (2021-2032)
5 Semi-synthetic β-lactam Antibiotics Market by Application
  1. 5.1 Semi-synthetic β-lactam Antibiotics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application
  6. 5.2.1 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Semi-synthetic β-lactam Antibiotics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Semi-synthetic β-lactam Antibiotics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Semi-synthetic β-lactam Antibiotics Sales Value by Application
  10. 5.3.1 Global Semi-synthetic β-lactam Antibiotics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Semi-synthetic β-lactam Antibiotics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Semi-synthetic β-lactam Antibiotics Sales Value Share by Application (2021-2032)
6 Semi-synthetic β-lactam Antibiotics Regional Sales and Value Analysis
  1. 6.1 Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Semi-synthetic β-lactam Antibiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Semi-synthetic β-lactam Antibiotics Sales by Region (2027-2032)
  5. 6.3 Global Semi-synthetic β-lactam Antibiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Semi-synthetic β-lactam Antibiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Semi-synthetic β-lactam Antibiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Semi-synthetic β-lactam Antibiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Semi-synthetic β-lactam Antibiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  12. 6.6.2 North America Semi-synthetic β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Semi-synthetic β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Semi-synthetic β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  21. 6.9.2 South America Semi-synthetic β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Semi-synthetic β-lactam Antibiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Semi-synthetic β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
7 Semi-synthetic β-lactam Antibiotics Country-level Sales and Value Analysis
  1. 7.1 Global Semi-synthetic β-lactam Antibiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Semi-synthetic β-lactam Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Semi-synthetic β-lactam Antibiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Semi-synthetic β-lactam Antibiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Semi-synthetic β-lactam Antibiotics Sales by Country (2027-2032)
  6. 7.4 Global Semi-synthetic β-lactam Antibiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Semi-synthetic β-lactam Antibiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Semi-synthetic β-lactam Antibiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Semi-synthetic β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Semi-synthetic β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Semi-synthetic β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Semi-synthetic β-lactam Antibiotics Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Weiqida
  8. 8.2.1 Weiqida Company Information
  9. 8.2.2 Weiqida Business Overview
  10. 8.2.3 Weiqida Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Weiqida Semi-synthetic β-lactam Antibiotics Product Portfolio
  12. 8.2.5 Weiqida Recent Developments
  13. 8.3 Lukang Pharmaceuticals
  14. 8.3.1 Lukang Pharmaceuticals Company Information
  15. 8.3.2 Lukang Pharmaceuticals Business Overview
  16. 8.3.3 Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  18. 8.3.5 Lukang Pharmaceuticals Recent Developments
  19. 8.4 United Pharmaceuticals
  20. 8.4.1 United Pharmaceuticals Company Information
  21. 8.4.2 United Pharmaceuticals Business Overview
  22. 8.4.3 United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  24. 8.4.5 United Pharmaceuticals Recent Developments
  25. 8.5 Huayao International
  26. 8.5.1 Huayao International Company Information
  27. 8.5.2 Huayao International Business Overview
  28. 8.5.3 Huayao International Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Huayao International Semi-synthetic β-lactam Antibiotics Product Portfolio
  30. 8.5.5 Huayao International Recent Developments
  31. 8.6 North China Pharmaceuticals
  32. 8.6.1 North China Pharmaceuticals Company Information
  33. 8.6.2 North China Pharmaceuticals Business Overview
  34. 8.6.3 North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  36. 8.6.5 North China Pharmaceuticals Recent Developments
  37. 8.7 Harbin Pharmaceuticals
  38. 8.7.1 Harbin Pharmaceuticals Company Information
  39. 8.7.2 Harbin Pharmaceuticals Business Overview
  40. 8.7.3 Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  42. 8.7.5 Harbin Pharmaceuticals Recent Developments
  43. 8.8 Chuanning Biopharmaceuticals
  44. 8.8.1 Chuanning Biopharmaceuticals Company Information
  45. 8.8.2 Chuanning Biopharmaceuticals Business Overview
  46. 8.8.3 Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  48. 8.8.5 Chuanning Biopharmaceuticals Recent Developments
  49. 8.9 Changsheng Pharmaceuticals
  50. 8.9.1 Changsheng Pharmaceuticals Company Information
  51. 8.9.2 Changsheng Pharmaceuticals Business Overview
  52. 8.9.3 Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
  54. 8.9.5 Changsheng Pharmaceuticals Recent Developments
  55. 8.10 Teva
  56. 8.10.1 Teva Company Information
  57. 8.10.2 Teva Business Overview
  58. 8.10.3 Teva Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Teva Semi-synthetic β-lactam Antibiotics Product Portfolio
  60. 8.10.5 Teva Recent Developments
  61. 8.11 Sun Pharma
  62. 8.11.1 Sun Pharma Company Information
  63. 8.11.2 Sun Pharma Business Overview
  64. 8.11.3 Sun Pharma Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sun Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio
  66. 8.11.5 Sun Pharma Recent Developments
  67. 8.12 Novartis
  68. 8.12.1 Novartis Company Information
  69. 8.12.2 Novartis Business Overview
  70. 8.12.3 Novartis Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Novartis Semi-synthetic β-lactam Antibiotics Product Portfolio
  72. 8.12.5 Novartis Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Semi-synthetic β-lactam Antibiotics Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Meiji Holdings
  80. 8.14.1 Meiji Holdings Company Information
  81. 8.14.2 Meiji Holdings Business Overview
  82. 8.14.3 Meiji Holdings Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Meiji Holdings Semi-synthetic β-lactam Antibiotics Product Portfolio
  84. 8.14.5 Meiji Holdings Recent Developments
  85. 8.15 Hikma
  86. 8.15.1 Hikma Company Information
  87. 8.15.2 Hikma Business Overview
  88. 8.15.3 Hikma Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hikma Semi-synthetic β-lactam Antibiotics Product Portfolio
  90. 8.15.5 Hikma Recent Developments
  91. 8.16 DSM
  92. 8.16.1 DSM Company Information
  93. 8.16.2 DSM Business Overview
  94. 8.16.3 DSM Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 DSM Semi-synthetic β-lactam Antibiotics Product Portfolio
  96. 8.16.5 DSM Recent Developments
  97. 8.17 Dr. Reddy
  98. 8.17.1 Dr. Reddy Company Information
  99. 8.17.2 Dr. Reddy Business Overview
  100. 8.17.3 Dr. Reddy Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy Semi-synthetic β-lactam Antibiotics Product Portfolio
  102. 8.17.5 Dr. Reddy Recent Developments
  103. 8.18 Cipla
  104. 8.18.1 Cipla Company Information
  105. 8.18.2 Cipla Business Overview
  106. 8.18.3 Cipla Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Cipla Semi-synthetic β-lactam Antibiotics Product Portfolio
  108. 8.18.5 Cipla Recent Developments
  109. 8.19 Centrient Pharma
  110. 8.19.1 Centrient Pharma Company Information
  111. 8.19.2 Centrient Pharma Business Overview
  112. 8.19.3 Centrient Pharma Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Centrient Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio
  114. 8.19.5 Centrient Pharma Recent Developments
  115. 8.20 Aurubindo
  116. 8.20.1 Aurubindo Company Information
  117. 8.20.2 Aurubindo Business Overview
  118. 8.20.3 Aurubindo Semi-synthetic β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Aurubindo Semi-synthetic β-lactam Antibiotics Product Portfolio
  120. 8.20.5 Aurubindo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Semi-synthetic β-lactam Antibiotics Value Chain Analysis
  2. 9.1.1 Semi-synthetic β-lactam Antibiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Semi-synthetic β-lactam Antibiotics Sales Mode & Process
  6. 9.2 Semi-synthetic β-lactam Antibiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Semi-synthetic β-lactam Antibiotics Distributors
  9. 9.2.3 Semi-synthetic β-lactam Antibiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst